Global Pharmacovigilance Services Market Research Report 2026(Status and Outlook)
Pharmacovigilance Services refers to a series of professional services designed to monitor, assess, identify, and prevent adverse reactions and other drug-related safety risks that may occur during the research and development, production, distribution, and use of drugs (including pharmaceuticals, biologics, and medical devices). The core goal of these services is to ensure public medication safety. By systematically collecting and analyzing drug safety data, potential safety signals are promptly identified, providing scientific evidence to drug regulatory agencies, pharmaceutical companies, and healthcare institutions. This supports safe drug use, label updates, the development of risk control measures (such as issuing safety alerts and restricting use), and even assists in decision-making regarding drug recalls when necessary.Artificial intelligence and machine learning technologies are revolutionizing pharmacovigilance adverse event monitoring and data management processes, improving efficiency and accuracy. For example, contract research organizations (CROs) are increasingly using AI to automate tasks such as medical coding of adverse event reports. This not only reduces manual labor but also improves data consistency, helping to meet stringent regulatory requirements.Many pharmaceutical companies are outsourcing pharmacovigilance activities to specialized organizations with advanced technology platforms. This allows them to better manage increasingly complex data while focusing on their core business. Leveraging the expertise of these specialized organizations can improve operational efficiency and promote safer pharmaceutical manufacturing practices.Increasingly stringent global regulatory frameworks, with agencies such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) placing greater emphasis on ensuring that drugs and vaccines meet stringent safety standards throughout their lifecycles, are prompting pharmaceutical companies to increase their investment in pharmacovigilance services to meet regulatory requirements.The Asia-Pacific region is one of the fastest-growing regions in the global pharmacovigilance services industry. Driven by the rapid development of the region's pharmaceutical industry and the increasing emphasis on drug safety regulation by governments, demand in the Asia-Pacific market continues to grow.
The global Pharmacovigilance Services market size was estimated at USD 1464.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pharmacovigilance Services market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pharmacovigilance Services market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pharmacovigilance Services market.
Global Pharmacovigilance Services Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
PrimeVigilance
Quanticate
ProPharma Group
Parexel
Accenture
Aixial Group
SGS
Medpace
Universal Medica Group
QVigilance
Freyr Solutions
Navitas Life Sciences
MMS Holdings
Amarex
Astrix Technology Group
Cambridge Regulatory Services
CROMSOURCE
APCER Life Sciences
Pharmya
A+Science
Midas Pharma
George Clinical
Syneos Health
INPHARMATIS
Taimei Technology
Extedo
WCG Clinical
Market Segmentation (by Type)
Adverse Event Case Management
Aggregate Reporting
Signal Intelligence
Risk Management
Market Segmentation (by Application)
Biotechnology and Pharmaceuticals
Contract Research Organization
Hospital
KPO / BPO
Healthcare Institutions
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pharmacovigilance Services Market
Overview of the regional outlook of the Pharmacovigilance Services Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacovigilance Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pharmacovigilance Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Pharmacovigilance Services market size was estimated at USD 1464.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pharmacovigilance Services market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pharmacovigilance Services market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pharmacovigilance Services market.
Global Pharmacovigilance Services Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
PrimeVigilance
Quanticate
ProPharma Group
Parexel
Accenture
Aixial Group
SGS
Medpace
Universal Medica Group
QVigilance
Freyr Solutions
Navitas Life Sciences
MMS Holdings
Amarex
Astrix Technology Group
Cambridge Regulatory Services
CROMSOURCE
APCER Life Sciences
Pharmya
A+Science
Midas Pharma
George Clinical
Syneos Health
INPHARMATIS
Taimei Technology
Extedo
WCG Clinical
Market Segmentation (by Type)
Adverse Event Case Management
Aggregate Reporting
Signal Intelligence
Risk Management
Market Segmentation (by Application)
Biotechnology and Pharmaceuticals
Contract Research Organization
Hospital
KPO / BPO
Healthcare Institutions
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pharmacovigilance Services Market
Overview of the regional outlook of the Pharmacovigilance Services Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacovigilance Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pharmacovigilance Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pharmacovigilance Services
1.2 Key Market Segments
1.2.1 Pharmacovigilance Services Segment by Type
1.2.2 Pharmacovigilance Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACOVIGILANCE SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmacovigilance Services Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pharmacovigilance Services Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACOVIGILANCE SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pharmacovigilance Services Product Life Cycle
3.3 Global Pharmacovigilance Services Sales by Manufacturers (2020-2025)
3.4 Global Pharmacovigilance Services Revenue Market Share by Manufacturers (2020-2025)
3.5 Pharmacovigilance Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pharmacovigilance Services Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pharmacovigilance Services Market Competitive Situation and Trends
3.8.1 Pharmacovigilance Services Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pharmacovigilance Services Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PHARMACOVIGILANCE SERVICES INDUSTRY CHAIN ANALYSIS
4.1 Pharmacovigilance Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACOVIGILANCE SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pharmacovigilance Services Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pharmacovigilance Services Market
5.7 ESG Ratings of Leading Companies
6 PHARMACOVIGILANCE SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacovigilance Services Sales Market Share by Type (2020-2025)
6.3 Global Pharmacovigilance Services Market Size by Type (2020-2025)
6.4 Global Pharmacovigilance Services Price by Type (2020-2025)
7 PHARMACOVIGILANCE SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacovigilance Services Market Sales by Application (2020-2025)
7.3 Global Pharmacovigilance Services Market Size (M USD) by Application (2020-2025)
7.4 Global Pharmacovigilance Services Sales Growth Rate by Application (2020-2025)
8 PHARMACOVIGILANCE SERVICES MARKET SALES BY REGION
8.1 Global Pharmacovigilance Services Sales by Region
8.1.1 Global Pharmacovigilance Services Sales by Region
8.1.2 Global Pharmacovigilance Services Sales Market Share by Region
8.2 Global Pharmacovigilance Services Market Size by Region
8.2.1 Global Pharmacovigilance Services Market Size by Region
8.2.2 Global Pharmacovigilance Services Market Size by Region
8.3 North America
8.3.1 North America Pharmacovigilance Services Sales by Country
8.3.2 North America Pharmacovigilance Services Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pharmacovigilance Services Sales by Country
8.4.2 Europe Pharmacovigilance Services Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pharmacovigilance Services Sales by Region
8.5.2 Asia Pacific Pharmacovigilance Services Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pharmacovigilance Services Sales by Country
8.6.2 South America Pharmacovigilance Services Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pharmacovigilance Services Sales by Region
8.7.2 Middle East and Africa Pharmacovigilance Services Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PHARMACOVIGILANCE SERVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Pharmacovigilance Services by Region(2020-2025)
9.2 Global Pharmacovigilance Services Revenue Market Share by Region (2020-2025)
9.3 Global Pharmacovigilance Services Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pharmacovigilance Services Production
9.4.1 North America Pharmacovigilance Services Production Growth Rate (2020-2025)
9.4.2 North America Pharmacovigilance Services Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pharmacovigilance Services Production
9.5.1 Europe Pharmacovigilance Services Production Growth Rate (2020-2025)
9.5.2 Europe Pharmacovigilance Services Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pharmacovigilance Services Production (2020-2025)
9.6.1 Japan Pharmacovigilance Services Production Growth Rate (2020-2025)
9.6.2 Japan Pharmacovigilance Services Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pharmacovigilance Services Production (2020-2025)
9.7.1 China Pharmacovigilance Services Production Growth Rate (2020-2025)
9.7.2 China Pharmacovigilance Services Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 PrimeVigilance
10.1.1 PrimeVigilance Basic Information
10.1.2 PrimeVigilance Pharmacovigilance Services Product Overview
10.1.3 PrimeVigilance Pharmacovigilance Services Product Market Performance
10.1.4 PrimeVigilance Business Overview
10.1.5 PrimeVigilance SWOT Analysis
10.1.6 PrimeVigilance Recent Developments
10.2 Quanticate
10.2.1 Quanticate Basic Information
10.2.2 Quanticate Pharmacovigilance Services Product Overview
10.2.3 Quanticate Pharmacovigilance Services Product Market Performance
10.2.4 Quanticate Business Overview
10.2.5 Quanticate SWOT Analysis
10.2.6 Quanticate Recent Developments
10.3 ProPharma Group
10.3.1 ProPharma Group Basic Information
10.3.2 ProPharma Group Pharmacovigilance Services Product Overview
10.3.3 ProPharma Group Pharmacovigilance Services Product Market Performance
10.3.4 ProPharma Group Business Overview
10.3.5 ProPharma Group SWOT Analysis
10.3.6 ProPharma Group Recent Developments
10.4 Parexel
10.4.1 Parexel Basic Information
10.4.2 Parexel Pharmacovigilance Services Product Overview
10.4.3 Parexel Pharmacovigilance Services Product Market Performance
10.4.4 Parexel Business Overview
10.4.5 Parexel Recent Developments
10.5 Accenture
10.5.1 Accenture Basic Information
10.5.2 Accenture Pharmacovigilance Services Product Overview
10.5.3 Accenture Pharmacovigilance Services Product Market Performance
10.5.4 Accenture Business Overview
10.5.5 Accenture Recent Developments
10.6 Aixial Group
10.6.1 Aixial Group Basic Information
10.6.2 Aixial Group Pharmacovigilance Services Product Overview
10.6.3 Aixial Group Pharmacovigilance Services Product Market Performance
10.6.4 Aixial Group Business Overview
10.6.5 Aixial Group Recent Developments
10.7 SGS
10.7.1 SGS Basic Information
10.7.2 SGS Pharmacovigilance Services Product Overview
10.7.3 SGS Pharmacovigilance Services Product Market Performance
10.7.4 SGS Business Overview
10.7.5 SGS Recent Developments
10.8 Medpace
10.8.1 Medpace Basic Information
10.8.2 Medpace Pharmacovigilance Services Product Overview
10.8.3 Medpace Pharmacovigilance Services Product Market Performance
10.8.4 Medpace Business Overview
10.8.5 Medpace Recent Developments
10.9 Universal Medica Group
10.9.1 Universal Medica Group Basic Information
10.9.2 Universal Medica Group Pharmacovigilance Services Product Overview
10.9.3 Universal Medica Group Pharmacovigilance Services Product Market Performance
10.9.4 Universal Medica Group Business Overview
10.9.5 Universal Medica Group Recent Developments
10.10 QVigilance
10.10.1 QVigilance Basic Information
10.10.2 QVigilance Pharmacovigilance Services Product Overview
10.10.3 QVigilance Pharmacovigilance Services Product Market Performance
10.10.4 QVigilance Business Overview
10.10.5 QVigilance Recent Developments
10.11 Freyr Solutions
10.11.1 Freyr Solutions Basic Information
10.11.2 Freyr Solutions Pharmacovigilance Services Product Overview
10.11.3 Freyr Solutions Pharmacovigilance Services Product Market Performance
10.11.4 Freyr Solutions Business Overview
10.11.5 Freyr Solutions Recent Developments
10.12 Navitas Life Sciences
10.12.1 Navitas Life Sciences Basic Information
10.12.2 Navitas Life Sciences Pharmacovigilance Services Product Overview
10.12.3 Navitas Life Sciences Pharmacovigilance Services Product Market Performance
10.12.4 Navitas Life Sciences Business Overview
10.12.5 Navitas Life Sciences Recent Developments
10.13 MMS Holdings
10.13.1 MMS Holdings Basic Information
10.13.2 MMS Holdings Pharmacovigilance Services Product Overview
10.13.3 MMS Holdings Pharmacovigilance Services Product Market Performance
10.13.4 MMS Holdings Business Overview
10.13.5 MMS Holdings Recent Developments
10.14 Amarex
10.14.1 Amarex Basic Information
10.14.2 Amarex Pharmacovigilance Services Product Overview
10.14.3 Amarex Pharmacovigilance Services Product Market Performance
10.14.4 Amarex Business Overview
10.14.5 Amarex Recent Developments
10.15 Astrix Technology Group
10.15.1 Astrix Technology Group Basic Information
10.15.2 Astrix Technology Group Pharmacovigilance Services Product Overview
10.15.3 Astrix Technology Group Pharmacovigilance Services Product Market Performance
10.15.4 Astrix Technology Group Business Overview
10.15.5 Astrix Technology Group Recent Developments
10.16 Cambridge Regulatory Services
10.16.1 Cambridge Regulatory Services Basic Information
10.16.2 Cambridge Regulatory Services Pharmacovigilance Services Product Overview
10.16.3 Cambridge Regulatory Services Pharmacovigilance Services Product Market Performance
10.16.4 Cambridge Regulatory Services Business Overview
10.16.5 Cambridge Regulatory Services Recent Developments
10.17 CROMSOURCE
10.17.1 CROMSOURCE Basic Information
10.17.2 CROMSOURCE Pharmacovigilance Services Product Overview
10.17.3 CROMSOURCE Pharmacovigilance Services Product Market Performance
10.17.4 CROMSOURCE Business Overview
10.17.5 CROMSOURCE Recent Developments
10.18 APCER Life Sciences
10.18.1 APCER Life Sciences Basic Information
10.18.2 APCER Life Sciences Pharmacovigilance Services Product Overview
10.18.3 APCER Life Sciences Pharmacovigilance Services Product Market Performance
10.18.4 APCER Life Sciences Business Overview
10.18.5 APCER Life Sciences Recent Developments
10.19 Pharmya
10.19.1 Pharmya Basic Information
10.19.2 Pharmya Pharmacovigilance Services Product Overview
10.19.3 Pharmya Pharmacovigilance Services Product Market Performance
10.19.4 Pharmya Business Overview
10.19.5 Pharmya Recent Developments
10.20 A+Science
10.20.1 A+Science Basic Information
10.20.2 A+Science Pharmacovigilance Services Product Overview
10.20.3 A+Science Pharmacovigilance Services Product Market Performance
10.20.4 A+Science Business Overview
10.20.5 A+Science Recent Developments
10.21 Midas Pharma
10.21.1 Midas Pharma Basic Information
10.21.2 Midas Pharma Pharmacovigilance Services Product Overview
10.21.3 Midas Pharma Pharmacovigilance Services Product Market Performance
10.21.4 Midas Pharma Business Overview
10.21.5 Midas Pharma Recent Developments
10.22 George Clinical
10.22.1 George Clinical Basic Information
10.22.2 George Clinical Pharmacovigilance Services Product Overview
10.22.3 George Clinical Pharmacovigilance Services Product Market Performance
10.22.4 George Clinical Business Overview
10.22.5 George Clinical Recent Developments
10.23 Syneos Health
10.23.1 Syneos Health Basic Information
10.23.2 Syneos Health Pharmacovigilance Services Product Overview
10.23.3 Syneos Health Pharmacovigilance Services Product Market Performance
10.23.4 Syneos Health Business Overview
10.23.5 Syneos Health Recent Developments
10.24 INPHARMATIS
10.24.1 INPHARMATIS Basic Information
10.24.2 INPHARMATIS Pharmacovigilance Services Product Overview
10.24.3 INPHARMATIS Pharmacovigilance Services Product Market Performance
10.24.4 INPHARMATIS Business Overview
10.24.5 INPHARMATIS Recent Developments
10.25 Taimei Technology
10.25.1 Taimei Technology Basic Information
10.25.2 Taimei Technology Pharmacovigilance Services Product Overview
10.25.3 Taimei Technology Pharmacovigilance Services Product Market Performance
10.25.4 Taimei Technology Business Overview
10.25.5 Taimei Technology Recent Developments
10.26 Extedo
10.26.1 Extedo Basic Information
10.26.2 Extedo Pharmacovigilance Services Product Overview
10.26.3 Extedo Pharmacovigilance Services Product Market Performance
10.26.4 Extedo Business Overview
10.26.5 Extedo Recent Developments
10.27 WCG Clinical
10.27.1 WCG Clinical Basic Information
10.27.2 WCG Clinical Pharmacovigilance Services Product Overview
10.27.3 WCG Clinical Pharmacovigilance Services Product Market Performance
10.27.4 WCG Clinical Business Overview
10.27.5 WCG Clinical Recent Developments
11 PHARMACOVIGILANCE SERVICES MARKET FORECAST BY REGION
11.1 Global Pharmacovigilance Services Market Size Forecast
11.2 Global Pharmacovigilance Services Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pharmacovigilance Services Market Size Forecast by Country
11.2.3 Asia Pacific Pharmacovigilance Services Market Size Forecast by Region
11.2.4 South America Pharmacovigilance Services Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pharmacovigilance Services by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pharmacovigilance Services Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pharmacovigilance Services by Type (2026-2035)
12.1.2 Global Pharmacovigilance Services Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pharmacovigilance Services by Type (2026-2035)
12.2 Global Pharmacovigilance Services Market Forecast by Application (2026-2035)
12.2.1 Global Pharmacovigilance Services Sales (K Units) Forecast by Application
12.2.2 Global Pharmacovigilance Services Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pharmacovigilance Services
1.2 Key Market Segments
1.2.1 Pharmacovigilance Services Segment by Type
1.2.2 Pharmacovigilance Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACOVIGILANCE SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmacovigilance Services Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pharmacovigilance Services Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACOVIGILANCE SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pharmacovigilance Services Product Life Cycle
3.3 Global Pharmacovigilance Services Sales by Manufacturers (2020-2025)
3.4 Global Pharmacovigilance Services Revenue Market Share by Manufacturers (2020-2025)
3.5 Pharmacovigilance Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pharmacovigilance Services Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pharmacovigilance Services Market Competitive Situation and Trends
3.8.1 Pharmacovigilance Services Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pharmacovigilance Services Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PHARMACOVIGILANCE SERVICES INDUSTRY CHAIN ANALYSIS
4.1 Pharmacovigilance Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACOVIGILANCE SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pharmacovigilance Services Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pharmacovigilance Services Market
5.7 ESG Ratings of Leading Companies
6 PHARMACOVIGILANCE SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacovigilance Services Sales Market Share by Type (2020-2025)
6.3 Global Pharmacovigilance Services Market Size by Type (2020-2025)
6.4 Global Pharmacovigilance Services Price by Type (2020-2025)
7 PHARMACOVIGILANCE SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacovigilance Services Market Sales by Application (2020-2025)
7.3 Global Pharmacovigilance Services Market Size (M USD) by Application (2020-2025)
7.4 Global Pharmacovigilance Services Sales Growth Rate by Application (2020-2025)
8 PHARMACOVIGILANCE SERVICES MARKET SALES BY REGION
8.1 Global Pharmacovigilance Services Sales by Region
8.1.1 Global Pharmacovigilance Services Sales by Region
8.1.2 Global Pharmacovigilance Services Sales Market Share by Region
8.2 Global Pharmacovigilance Services Market Size by Region
8.2.1 Global Pharmacovigilance Services Market Size by Region
8.2.2 Global Pharmacovigilance Services Market Size by Region
8.3 North America
8.3.1 North America Pharmacovigilance Services Sales by Country
8.3.2 North America Pharmacovigilance Services Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pharmacovigilance Services Sales by Country
8.4.2 Europe Pharmacovigilance Services Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pharmacovigilance Services Sales by Region
8.5.2 Asia Pacific Pharmacovigilance Services Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pharmacovigilance Services Sales by Country
8.6.2 South America Pharmacovigilance Services Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pharmacovigilance Services Sales by Region
8.7.2 Middle East and Africa Pharmacovigilance Services Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PHARMACOVIGILANCE SERVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Pharmacovigilance Services by Region(2020-2025)
9.2 Global Pharmacovigilance Services Revenue Market Share by Region (2020-2025)
9.3 Global Pharmacovigilance Services Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pharmacovigilance Services Production
9.4.1 North America Pharmacovigilance Services Production Growth Rate (2020-2025)
9.4.2 North America Pharmacovigilance Services Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pharmacovigilance Services Production
9.5.1 Europe Pharmacovigilance Services Production Growth Rate (2020-2025)
9.5.2 Europe Pharmacovigilance Services Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pharmacovigilance Services Production (2020-2025)
9.6.1 Japan Pharmacovigilance Services Production Growth Rate (2020-2025)
9.6.2 Japan Pharmacovigilance Services Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pharmacovigilance Services Production (2020-2025)
9.7.1 China Pharmacovigilance Services Production Growth Rate (2020-2025)
9.7.2 China Pharmacovigilance Services Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 PrimeVigilance
10.1.1 PrimeVigilance Basic Information
10.1.2 PrimeVigilance Pharmacovigilance Services Product Overview
10.1.3 PrimeVigilance Pharmacovigilance Services Product Market Performance
10.1.4 PrimeVigilance Business Overview
10.1.5 PrimeVigilance SWOT Analysis
10.1.6 PrimeVigilance Recent Developments
10.2 Quanticate
10.2.1 Quanticate Basic Information
10.2.2 Quanticate Pharmacovigilance Services Product Overview
10.2.3 Quanticate Pharmacovigilance Services Product Market Performance
10.2.4 Quanticate Business Overview
10.2.5 Quanticate SWOT Analysis
10.2.6 Quanticate Recent Developments
10.3 ProPharma Group
10.3.1 ProPharma Group Basic Information
10.3.2 ProPharma Group Pharmacovigilance Services Product Overview
10.3.3 ProPharma Group Pharmacovigilance Services Product Market Performance
10.3.4 ProPharma Group Business Overview
10.3.5 ProPharma Group SWOT Analysis
10.3.6 ProPharma Group Recent Developments
10.4 Parexel
10.4.1 Parexel Basic Information
10.4.2 Parexel Pharmacovigilance Services Product Overview
10.4.3 Parexel Pharmacovigilance Services Product Market Performance
10.4.4 Parexel Business Overview
10.4.5 Parexel Recent Developments
10.5 Accenture
10.5.1 Accenture Basic Information
10.5.2 Accenture Pharmacovigilance Services Product Overview
10.5.3 Accenture Pharmacovigilance Services Product Market Performance
10.5.4 Accenture Business Overview
10.5.5 Accenture Recent Developments
10.6 Aixial Group
10.6.1 Aixial Group Basic Information
10.6.2 Aixial Group Pharmacovigilance Services Product Overview
10.6.3 Aixial Group Pharmacovigilance Services Product Market Performance
10.6.4 Aixial Group Business Overview
10.6.5 Aixial Group Recent Developments
10.7 SGS
10.7.1 SGS Basic Information
10.7.2 SGS Pharmacovigilance Services Product Overview
10.7.3 SGS Pharmacovigilance Services Product Market Performance
10.7.4 SGS Business Overview
10.7.5 SGS Recent Developments
10.8 Medpace
10.8.1 Medpace Basic Information
10.8.2 Medpace Pharmacovigilance Services Product Overview
10.8.3 Medpace Pharmacovigilance Services Product Market Performance
10.8.4 Medpace Business Overview
10.8.5 Medpace Recent Developments
10.9 Universal Medica Group
10.9.1 Universal Medica Group Basic Information
10.9.2 Universal Medica Group Pharmacovigilance Services Product Overview
10.9.3 Universal Medica Group Pharmacovigilance Services Product Market Performance
10.9.4 Universal Medica Group Business Overview
10.9.5 Universal Medica Group Recent Developments
10.10 QVigilance
10.10.1 QVigilance Basic Information
10.10.2 QVigilance Pharmacovigilance Services Product Overview
10.10.3 QVigilance Pharmacovigilance Services Product Market Performance
10.10.4 QVigilance Business Overview
10.10.5 QVigilance Recent Developments
10.11 Freyr Solutions
10.11.1 Freyr Solutions Basic Information
10.11.2 Freyr Solutions Pharmacovigilance Services Product Overview
10.11.3 Freyr Solutions Pharmacovigilance Services Product Market Performance
10.11.4 Freyr Solutions Business Overview
10.11.5 Freyr Solutions Recent Developments
10.12 Navitas Life Sciences
10.12.1 Navitas Life Sciences Basic Information
10.12.2 Navitas Life Sciences Pharmacovigilance Services Product Overview
10.12.3 Navitas Life Sciences Pharmacovigilance Services Product Market Performance
10.12.4 Navitas Life Sciences Business Overview
10.12.5 Navitas Life Sciences Recent Developments
10.13 MMS Holdings
10.13.1 MMS Holdings Basic Information
10.13.2 MMS Holdings Pharmacovigilance Services Product Overview
10.13.3 MMS Holdings Pharmacovigilance Services Product Market Performance
10.13.4 MMS Holdings Business Overview
10.13.5 MMS Holdings Recent Developments
10.14 Amarex
10.14.1 Amarex Basic Information
10.14.2 Amarex Pharmacovigilance Services Product Overview
10.14.3 Amarex Pharmacovigilance Services Product Market Performance
10.14.4 Amarex Business Overview
10.14.5 Amarex Recent Developments
10.15 Astrix Technology Group
10.15.1 Astrix Technology Group Basic Information
10.15.2 Astrix Technology Group Pharmacovigilance Services Product Overview
10.15.3 Astrix Technology Group Pharmacovigilance Services Product Market Performance
10.15.4 Astrix Technology Group Business Overview
10.15.5 Astrix Technology Group Recent Developments
10.16 Cambridge Regulatory Services
10.16.1 Cambridge Regulatory Services Basic Information
10.16.2 Cambridge Regulatory Services Pharmacovigilance Services Product Overview
10.16.3 Cambridge Regulatory Services Pharmacovigilance Services Product Market Performance
10.16.4 Cambridge Regulatory Services Business Overview
10.16.5 Cambridge Regulatory Services Recent Developments
10.17 CROMSOURCE
10.17.1 CROMSOURCE Basic Information
10.17.2 CROMSOURCE Pharmacovigilance Services Product Overview
10.17.3 CROMSOURCE Pharmacovigilance Services Product Market Performance
10.17.4 CROMSOURCE Business Overview
10.17.5 CROMSOURCE Recent Developments
10.18 APCER Life Sciences
10.18.1 APCER Life Sciences Basic Information
10.18.2 APCER Life Sciences Pharmacovigilance Services Product Overview
10.18.3 APCER Life Sciences Pharmacovigilance Services Product Market Performance
10.18.4 APCER Life Sciences Business Overview
10.18.5 APCER Life Sciences Recent Developments
10.19 Pharmya
10.19.1 Pharmya Basic Information
10.19.2 Pharmya Pharmacovigilance Services Product Overview
10.19.3 Pharmya Pharmacovigilance Services Product Market Performance
10.19.4 Pharmya Business Overview
10.19.5 Pharmya Recent Developments
10.20 A+Science
10.20.1 A+Science Basic Information
10.20.2 A+Science Pharmacovigilance Services Product Overview
10.20.3 A+Science Pharmacovigilance Services Product Market Performance
10.20.4 A+Science Business Overview
10.20.5 A+Science Recent Developments
10.21 Midas Pharma
10.21.1 Midas Pharma Basic Information
10.21.2 Midas Pharma Pharmacovigilance Services Product Overview
10.21.3 Midas Pharma Pharmacovigilance Services Product Market Performance
10.21.4 Midas Pharma Business Overview
10.21.5 Midas Pharma Recent Developments
10.22 George Clinical
10.22.1 George Clinical Basic Information
10.22.2 George Clinical Pharmacovigilance Services Product Overview
10.22.3 George Clinical Pharmacovigilance Services Product Market Performance
10.22.4 George Clinical Business Overview
10.22.5 George Clinical Recent Developments
10.23 Syneos Health
10.23.1 Syneos Health Basic Information
10.23.2 Syneos Health Pharmacovigilance Services Product Overview
10.23.3 Syneos Health Pharmacovigilance Services Product Market Performance
10.23.4 Syneos Health Business Overview
10.23.5 Syneos Health Recent Developments
10.24 INPHARMATIS
10.24.1 INPHARMATIS Basic Information
10.24.2 INPHARMATIS Pharmacovigilance Services Product Overview
10.24.3 INPHARMATIS Pharmacovigilance Services Product Market Performance
10.24.4 INPHARMATIS Business Overview
10.24.5 INPHARMATIS Recent Developments
10.25 Taimei Technology
10.25.1 Taimei Technology Basic Information
10.25.2 Taimei Technology Pharmacovigilance Services Product Overview
10.25.3 Taimei Technology Pharmacovigilance Services Product Market Performance
10.25.4 Taimei Technology Business Overview
10.25.5 Taimei Technology Recent Developments
10.26 Extedo
10.26.1 Extedo Basic Information
10.26.2 Extedo Pharmacovigilance Services Product Overview
10.26.3 Extedo Pharmacovigilance Services Product Market Performance
10.26.4 Extedo Business Overview
10.26.5 Extedo Recent Developments
10.27 WCG Clinical
10.27.1 WCG Clinical Basic Information
10.27.2 WCG Clinical Pharmacovigilance Services Product Overview
10.27.3 WCG Clinical Pharmacovigilance Services Product Market Performance
10.27.4 WCG Clinical Business Overview
10.27.5 WCG Clinical Recent Developments
11 PHARMACOVIGILANCE SERVICES MARKET FORECAST BY REGION
11.1 Global Pharmacovigilance Services Market Size Forecast
11.2 Global Pharmacovigilance Services Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pharmacovigilance Services Market Size Forecast by Country
11.2.3 Asia Pacific Pharmacovigilance Services Market Size Forecast by Region
11.2.4 South America Pharmacovigilance Services Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pharmacovigilance Services by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pharmacovigilance Services Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pharmacovigilance Services by Type (2026-2035)
12.1.2 Global Pharmacovigilance Services Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pharmacovigilance Services by Type (2026-2035)
12.2 Global Pharmacovigilance Services Market Forecast by Application (2026-2035)
12.2.1 Global Pharmacovigilance Services Sales (K Units) Forecast by Application
12.2.2 Global Pharmacovigilance Services Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pharmacovigilance Services Market Size by Type (M USD)
Table 4. Global Pharmacovigilance Services Market Size by Application
Table 5. Pharmacovigilance Services Market Size Comparison by Region (M USD)
Table 6. Global Pharmacovigilance Services Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Pharmacovigilance Services Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pharmacovigilance Services Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pharmacovigilance Services Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance Services as of 2025)
Table 11. Global Market Pharmacovigilance Services Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Pharmacovigilance Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmacovigilance Services Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pharmacovigilance Services Sales by Type (K Units)
Table 27. Global Pharmacovigilance Services Market Size by Type (M USD)
Table 28. Global Pharmacovigilance Services Sales (K Units) by Type (2020-2025)
Table 29. Global Pharmacovigilance Services Sales Market Share by Type (2020-2025)
Table 30. Global Pharmacovigilance Services Market Size (M USD) by Type (2020-2025)
Table 31. Global Pharmacovigilance Services Market Share by Type (2020-2025)
Table 32. Global Pharmacovigilance Services Price (USD/Unit) by Type (2020-2025)
Table 33. Global Pharmacovigilance Services Sales (K Units) by Application
Table 34. Global Pharmacovigilance Services Market Size by Application
Table 35. Global Pharmacovigilance Services Sales by Application (2020-2025) & (K Units)
Table 36. Global Pharmacovigilance Services Sales Market Share by Application (2020-2025)
Table 37. Global Pharmacovigilance Services Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pharmacovigilance Services Market Share by Application (2020-2025)
Table 39. Global Pharmacovigilance Services Sales Growth Rate by Application (2020-2025)
Table 40. Global Pharmacovigilance Services Sales by Region (2020-2025) & (K Units)
Table 41. Global Pharmacovigilance Services Sales Market Share by Region (2020-2025)
Table 42. Global Pharmacovigilance Services Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pharmacovigilance Services Market Size by Region (2020-2025)
Table 44. North America Pharmacovigilance Services Sales by Country (2020-2025) & (K Units)
Table 45. North America Pharmacovigilance Services Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pharmacovigilance Services Sales by Country (2020-2025) & (K Units)
Table 47. Europe Pharmacovigilance Services Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pharmacovigilance Services Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Pharmacovigilance Services Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pharmacovigilance Services Sales by Country (2020-2025) & (K Units)
Table 51. South America Pharmacovigilance Services Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pharmacovigilance Services Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Pharmacovigilance Services Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pharmacovigilance Services Production (K Units) by Region(2020-2025)
Table 55. Global Pharmacovigilance Services Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pharmacovigilance Services Revenue Market Share by Region (2020-2025)
Table 57. Global Pharmacovigilance Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Pharmacovigilance Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Pharmacovigilance Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Pharmacovigilance Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Pharmacovigilance Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. PrimeVigilance Basic Information
Table 63. PrimeVigilance Pharmacovigilance Services Product Overview
Table 64. PrimeVigilance Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. PrimeVigilance Business Overview
Table 66. PrimeVigilance SWOT Analysis
Table 67. PrimeVigilance Recent Developments
Table 68. Quanticate Basic Information
Table 69. Quanticate Pharmacovigilance Services Product Overview
Table 70. Quanticate Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Quanticate Business Overview
Table 72. Quanticate SWOT Analysis
Table 73. Quanticate Recent Developments
Table 74. ProPharma Group Basic Information
Table 75. ProPharma Group Pharmacovigilance Services Product Overview
Table 76. ProPharma Group Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. ProPharma Group Business Overview
Table 78. ProPharma Group SWOT Analysis
Table 79. ProPharma Group Recent Developments
Table 80. Parexel Basic Information
Table 81. Parexel Pharmacovigilance Services Product Overview
Table 82. Parexel Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Parexel Business Overview
Table 84. Parexel Recent Developments
Table 85. Accenture Basic Information
Table 86. Accenture Pharmacovigilance Services Product Overview
Table 87. Accenture Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Accenture Business Overview
Table 89. Accenture Recent Developments
Table 90. Aixial Group Basic Information
Table 91. Aixial Group Pharmacovigilance Services Product Overview
Table 92. Aixial Group Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Aixial Group Business Overview
Table 94. Aixial Group Recent Developments
Table 95. SGS Basic Information
Table 96. SGS Pharmacovigilance Services Product Overview
Table 97. SGS Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. SGS Business Overview
Table 99. SGS Recent Developments
Table 100. Medpace Basic Information
Table 101. Medpace Pharmacovigilance Services Product Overview
Table 102. Medpace Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Medpace Business Overview
Table 104. Medpace Recent Developments
Table 105. Universal Medica Group Basic Information
Table 106. Universal Medica Group Pharmacovigilance Services Product Overview
Table 107. Universal Medica Group Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Universal Medica Group Business Overview
Table 109. Universal Medica Group Recent Developments
Table 110. QVigilance Basic Information
Table 111. QVigilance Pharmacovigilance Services Product Overview
Table 112. QVigilance Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. QVigilance Business Overview
Table 114. QVigilance Recent Developments
Table 115. Freyr Solutions Basic Information
Table 116. Freyr Solutions Pharmacovigilance Services Product Overview
Table 117. Freyr Solutions Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Freyr Solutions Business Overview
Table 119. Freyr Solutions Recent Developments
Table 120. Navitas Life Sciences Basic Information
Table 121. Navitas Life Sciences Pharmacovigilance Services Product Overview
Table 122. Navitas Life Sciences Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Navitas Life Sciences Business Overview
Table 124. Navitas Life Sciences Recent Developments
Table 125. MMS Holdings Basic Information
Table 126. MMS Holdings Pharmacovigilance Services Product Overview
Table 127. MMS Holdings Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. MMS Holdings Business Overview
Table 129. MMS Holdings Recent Developments
Table 130. Amarex Basic Information
Table 131. Amarex Pharmacovigilance Services Product Overview
Table 132. Amarex Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Amarex Business Overview
Table 134. Amarex Recent Developments
Table 135. Astrix Technology Group Basic Information
Table 136. Astrix Technology Group Pharmacovigilance Services Product Overview
Table 137. Astrix Technology Group Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Astrix Technology Group Business Overview
Table 139. Astrix Technology Group Recent Developments
Table 140. Cambridge Regulatory Services Basic Information
Table 141. Cambridge Regulatory Services Pharmacovigilance Services Product Overview
Table 142. Cambridge Regulatory Services Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Cambridge Regulatory Services Business Overview
Table 144. Cambridge Regulatory Services Recent Developments
Table 145. CROMSOURCE Basic Information
Table 146. CROMSOURCE Pharmacovigilance Services Product Overview
Table 147. CROMSOURCE Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. CROMSOURCE Business Overview
Table 149. CROMSOURCE Recent Developments
Table 150. APCER Life Sciences Basic Information
Table 151. APCER Life Sciences Pharmacovigilance Services Product Overview
Table 152. APCER Life Sciences Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. APCER Life Sciences Business Overview
Table 154. APCER Life Sciences Recent Developments
Table 155. Pharmya Basic Information
Table 156. Pharmya Pharmacovigilance Services Product Overview
Table 157. Pharmya Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Pharmya Business Overview
Table 159. Pharmya Recent Developments
Table 160. A+Science Basic Information
Table 161. A+Science Pharmacovigilance Services Product Overview
Table 162. A+Science Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. A+Science Business Overview
Table 164. A+Science Recent Developments
Table 165. Midas Pharma Basic Information
Table 166. Midas Pharma Pharmacovigilance Services Product Overview
Table 167. Midas Pharma Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Midas Pharma Business Overview
Table 169. Midas Pharma Recent Developments
Table 170. George Clinical Basic Information
Table 171. George Clinical Pharmacovigilance Services Product Overview
Table 172. George Clinical Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. George Clinical Business Overview
Table 174. George Clinical Recent Developments
Table 175. Syneos Health Basic Information
Table 176. Syneos Health Pharmacovigilance Services Product Overview
Table 177. Syneos Health Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Syneos Health Business Overview
Table 179. Syneos Health Recent Developments
Table 180. INPHARMATIS Basic Information
Table 181. INPHARMATIS Pharmacovigilance Services Product Overview
Table 182. INPHARMATIS Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. INPHARMATIS Business Overview
Table 184. INPHARMATIS Recent Developments
Table 185. Taimei Technology Basic Information
Table 186. Taimei Technology Pharmacovigilance Services Product Overview
Table 187. Taimei Technology Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. Taimei Technology Business Overview
Table 189. Taimei Technology Recent Developments
Table 190. Extedo Basic Information
Table 191. Extedo Pharmacovigilance Services Product Overview
Table 192. Extedo Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 193. Extedo Business Overview
Table 194. Extedo Recent Developments
Table 195. WCG Clinical Basic Information
Table 196. WCG Clinical Pharmacovigilance Services Product Overview
Table 197. WCG Clinical Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 198. WCG Clinical Business Overview
Table 199. WCG Clinical Recent Developments
Table 200. Global Pharmacovigilance Services Sales Forecast by Region (2026-2035) & (K Units)
Table 201. Global Pharmacovigilance Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 202. North America Pharmacovigilance Services Sales Forecast by Country (2026-2035) & (K Units)
Table 203. North America Pharmacovigilance Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 204. Europe Pharmacovigilance Services Sales Forecast by Country (2026-2035) & (K Units)
Table 205. Europe Pharmacovigilance Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 206. Asia Pacific Pharmacovigilance Services Sales Forecast by Region (2026-2035) & (K Units)
Table 207. Asia Pacific Pharmacovigilance Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 208. South America Pharmacovigilance Services Sales Forecast by Country (2026-2035) & (K Units)
Table 209. South America Pharmacovigilance Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 210. Middle East and Africa Pharmacovigilance Services Sales Forecast by Country (2026-2035) & (Units)
Table 211. Middle East and Africa Pharmacovigilance Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 212. Global Pharmacovigilance Services Sales Forecast by Type (2026-2035) & (K Units)
Table 213. Global Pharmacovigilance Services Market Size Forecast by Type (2026-2035) & (M USD)
Table 214. Global Pharmacovigilance Services Price Forecast by Type (2026-2035) & (USD/Unit)
Table 215. Global Pharmacovigilance Services Sales (K Units) Forecast by Application (2026-2035)
Table 216. Global Pharmacovigilance Services Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pharmacovigilance Services Market Size by Type (M USD)
Table 4. Global Pharmacovigilance Services Market Size by Application
Table 5. Pharmacovigilance Services Market Size Comparison by Region (M USD)
Table 6. Global Pharmacovigilance Services Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Pharmacovigilance Services Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pharmacovigilance Services Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pharmacovigilance Services Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance Services as of 2025)
Table 11. Global Market Pharmacovigilance Services Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Pharmacovigilance Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmacovigilance Services Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pharmacovigilance Services Sales by Type (K Units)
Table 27. Global Pharmacovigilance Services Market Size by Type (M USD)
Table 28. Global Pharmacovigilance Services Sales (K Units) by Type (2020-2025)
Table 29. Global Pharmacovigilance Services Sales Market Share by Type (2020-2025)
Table 30. Global Pharmacovigilance Services Market Size (M USD) by Type (2020-2025)
Table 31. Global Pharmacovigilance Services Market Share by Type (2020-2025)
Table 32. Global Pharmacovigilance Services Price (USD/Unit) by Type (2020-2025)
Table 33. Global Pharmacovigilance Services Sales (K Units) by Application
Table 34. Global Pharmacovigilance Services Market Size by Application
Table 35. Global Pharmacovigilance Services Sales by Application (2020-2025) & (K Units)
Table 36. Global Pharmacovigilance Services Sales Market Share by Application (2020-2025)
Table 37. Global Pharmacovigilance Services Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pharmacovigilance Services Market Share by Application (2020-2025)
Table 39. Global Pharmacovigilance Services Sales Growth Rate by Application (2020-2025)
Table 40. Global Pharmacovigilance Services Sales by Region (2020-2025) & (K Units)
Table 41. Global Pharmacovigilance Services Sales Market Share by Region (2020-2025)
Table 42. Global Pharmacovigilance Services Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pharmacovigilance Services Market Size by Region (2020-2025)
Table 44. North America Pharmacovigilance Services Sales by Country (2020-2025) & (K Units)
Table 45. North America Pharmacovigilance Services Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pharmacovigilance Services Sales by Country (2020-2025) & (K Units)
Table 47. Europe Pharmacovigilance Services Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pharmacovigilance Services Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Pharmacovigilance Services Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pharmacovigilance Services Sales by Country (2020-2025) & (K Units)
Table 51. South America Pharmacovigilance Services Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pharmacovigilance Services Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Pharmacovigilance Services Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pharmacovigilance Services Production (K Units) by Region(2020-2025)
Table 55. Global Pharmacovigilance Services Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pharmacovigilance Services Revenue Market Share by Region (2020-2025)
Table 57. Global Pharmacovigilance Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Pharmacovigilance Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Pharmacovigilance Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Pharmacovigilance Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Pharmacovigilance Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. PrimeVigilance Basic Information
Table 63. PrimeVigilance Pharmacovigilance Services Product Overview
Table 64. PrimeVigilance Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. PrimeVigilance Business Overview
Table 66. PrimeVigilance SWOT Analysis
Table 67. PrimeVigilance Recent Developments
Table 68. Quanticate Basic Information
Table 69. Quanticate Pharmacovigilance Services Product Overview
Table 70. Quanticate Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Quanticate Business Overview
Table 72. Quanticate SWOT Analysis
Table 73. Quanticate Recent Developments
Table 74. ProPharma Group Basic Information
Table 75. ProPharma Group Pharmacovigilance Services Product Overview
Table 76. ProPharma Group Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. ProPharma Group Business Overview
Table 78. ProPharma Group SWOT Analysis
Table 79. ProPharma Group Recent Developments
Table 80. Parexel Basic Information
Table 81. Parexel Pharmacovigilance Services Product Overview
Table 82. Parexel Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Parexel Business Overview
Table 84. Parexel Recent Developments
Table 85. Accenture Basic Information
Table 86. Accenture Pharmacovigilance Services Product Overview
Table 87. Accenture Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Accenture Business Overview
Table 89. Accenture Recent Developments
Table 90. Aixial Group Basic Information
Table 91. Aixial Group Pharmacovigilance Services Product Overview
Table 92. Aixial Group Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Aixial Group Business Overview
Table 94. Aixial Group Recent Developments
Table 95. SGS Basic Information
Table 96. SGS Pharmacovigilance Services Product Overview
Table 97. SGS Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. SGS Business Overview
Table 99. SGS Recent Developments
Table 100. Medpace Basic Information
Table 101. Medpace Pharmacovigilance Services Product Overview
Table 102. Medpace Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Medpace Business Overview
Table 104. Medpace Recent Developments
Table 105. Universal Medica Group Basic Information
Table 106. Universal Medica Group Pharmacovigilance Services Product Overview
Table 107. Universal Medica Group Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Universal Medica Group Business Overview
Table 109. Universal Medica Group Recent Developments
Table 110. QVigilance Basic Information
Table 111. QVigilance Pharmacovigilance Services Product Overview
Table 112. QVigilance Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. QVigilance Business Overview
Table 114. QVigilance Recent Developments
Table 115. Freyr Solutions Basic Information
Table 116. Freyr Solutions Pharmacovigilance Services Product Overview
Table 117. Freyr Solutions Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Freyr Solutions Business Overview
Table 119. Freyr Solutions Recent Developments
Table 120. Navitas Life Sciences Basic Information
Table 121. Navitas Life Sciences Pharmacovigilance Services Product Overview
Table 122. Navitas Life Sciences Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Navitas Life Sciences Business Overview
Table 124. Navitas Life Sciences Recent Developments
Table 125. MMS Holdings Basic Information
Table 126. MMS Holdings Pharmacovigilance Services Product Overview
Table 127. MMS Holdings Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. MMS Holdings Business Overview
Table 129. MMS Holdings Recent Developments
Table 130. Amarex Basic Information
Table 131. Amarex Pharmacovigilance Services Product Overview
Table 132. Amarex Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Amarex Business Overview
Table 134. Amarex Recent Developments
Table 135. Astrix Technology Group Basic Information
Table 136. Astrix Technology Group Pharmacovigilance Services Product Overview
Table 137. Astrix Technology Group Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Astrix Technology Group Business Overview
Table 139. Astrix Technology Group Recent Developments
Table 140. Cambridge Regulatory Services Basic Information
Table 141. Cambridge Regulatory Services Pharmacovigilance Services Product Overview
Table 142. Cambridge Regulatory Services Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Cambridge Regulatory Services Business Overview
Table 144. Cambridge Regulatory Services Recent Developments
Table 145. CROMSOURCE Basic Information
Table 146. CROMSOURCE Pharmacovigilance Services Product Overview
Table 147. CROMSOURCE Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. CROMSOURCE Business Overview
Table 149. CROMSOURCE Recent Developments
Table 150. APCER Life Sciences Basic Information
Table 151. APCER Life Sciences Pharmacovigilance Services Product Overview
Table 152. APCER Life Sciences Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. APCER Life Sciences Business Overview
Table 154. APCER Life Sciences Recent Developments
Table 155. Pharmya Basic Information
Table 156. Pharmya Pharmacovigilance Services Product Overview
Table 157. Pharmya Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Pharmya Business Overview
Table 159. Pharmya Recent Developments
Table 160. A+Science Basic Information
Table 161. A+Science Pharmacovigilance Services Product Overview
Table 162. A+Science Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. A+Science Business Overview
Table 164. A+Science Recent Developments
Table 165. Midas Pharma Basic Information
Table 166. Midas Pharma Pharmacovigilance Services Product Overview
Table 167. Midas Pharma Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Midas Pharma Business Overview
Table 169. Midas Pharma Recent Developments
Table 170. George Clinical Basic Information
Table 171. George Clinical Pharmacovigilance Services Product Overview
Table 172. George Clinical Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. George Clinical Business Overview
Table 174. George Clinical Recent Developments
Table 175. Syneos Health Basic Information
Table 176. Syneos Health Pharmacovigilance Services Product Overview
Table 177. Syneos Health Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Syneos Health Business Overview
Table 179. Syneos Health Recent Developments
Table 180. INPHARMATIS Basic Information
Table 181. INPHARMATIS Pharmacovigilance Services Product Overview
Table 182. INPHARMATIS Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. INPHARMATIS Business Overview
Table 184. INPHARMATIS Recent Developments
Table 185. Taimei Technology Basic Information
Table 186. Taimei Technology Pharmacovigilance Services Product Overview
Table 187. Taimei Technology Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. Taimei Technology Business Overview
Table 189. Taimei Technology Recent Developments
Table 190. Extedo Basic Information
Table 191. Extedo Pharmacovigilance Services Product Overview
Table 192. Extedo Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 193. Extedo Business Overview
Table 194. Extedo Recent Developments
Table 195. WCG Clinical Basic Information
Table 196. WCG Clinical Pharmacovigilance Services Product Overview
Table 197. WCG Clinical Pharmacovigilance Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 198. WCG Clinical Business Overview
Table 199. WCG Clinical Recent Developments
Table 200. Global Pharmacovigilance Services Sales Forecast by Region (2026-2035) & (K Units)
Table 201. Global Pharmacovigilance Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 202. North America Pharmacovigilance Services Sales Forecast by Country (2026-2035) & (K Units)
Table 203. North America Pharmacovigilance Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 204. Europe Pharmacovigilance Services Sales Forecast by Country (2026-2035) & (K Units)
Table 205. Europe Pharmacovigilance Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 206. Asia Pacific Pharmacovigilance Services Sales Forecast by Region (2026-2035) & (K Units)
Table 207. Asia Pacific Pharmacovigilance Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 208. South America Pharmacovigilance Services Sales Forecast by Country (2026-2035) & (K Units)
Table 209. South America Pharmacovigilance Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 210. Middle East and Africa Pharmacovigilance Services Sales Forecast by Country (2026-2035) & (Units)
Table 211. Middle East and Africa Pharmacovigilance Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 212. Global Pharmacovigilance Services Sales Forecast by Type (2026-2035) & (K Units)
Table 213. Global Pharmacovigilance Services Market Size Forecast by Type (2026-2035) & (M USD)
Table 214. Global Pharmacovigilance Services Price Forecast by Type (2026-2035) & (USD/Unit)
Table 215. Global Pharmacovigilance Services Sales (K Units) Forecast by Application (2026-2035)
Table 216. Global Pharmacovigilance Services Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pharmacovigilance Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacovigilance Services Market Size (M USD), 2025-2035
Figure 5. Global Pharmacovigilance Services Market Size (M USD) (2020-2035)
Figure 6. Global Pharmacovigilance Services Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacovigilance Services Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pharmacovigilance Services Product Life Cycle
Figure 13. Pharmacovigilance Services Sales Share by Manufacturers in 2025
Figure 14. Global Pharmacovigilance Services Revenue Share by Manufacturers in 2025
Figure 15. Pharmacovigilance Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pharmacovigilance Services Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pharmacovigilance Services Revenue in 2025
Figure 18. Industry Chain Map of Pharmacovigilance Services
Figure 19. Global Pharmacovigilance Services Market PEST Analysis
Figure 20. Global Pharmacovigilance Services Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pharmacovigilance Services Market Share by Type
Figure 27. Sales Market Share of Pharmacovigilance Services by Type (2020-2025)
Figure 28. Sales Market Share of Pharmacovigilance Services by Type in 2025
Figure 29. Market Share of Pharmacovigilance Services by Type (2020-2025)
Figure 30. Market Share of Pharmacovigilance Services by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pharmacovigilance Services Market Share by Application
Figure 33. Global Pharmacovigilance Services Sales Market Share by Application (2020-2025)
Figure 34. Global Pharmacovigilance Services Sales Market Share by Application in 2025
Figure 35. Global Pharmacovigilance Services Market Share by Application (2020-2025)
Figure 36. Global Pharmacovigilance Services Market Share by Application in 2025
Figure 37. Global Pharmacovigilance Services Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pharmacovigilance Services Sales Market Share by Region (2020-2025)
Figure 39. Global Pharmacovigilance Services Market Size by Region (2020-2025)
Figure 40. North America Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Pharmacovigilance Services Sales Market Share by Country in 2024
Figure 43. North America Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pharmacovigilance Services Market Size by Country in 2024
Figure 45. U.S. Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pharmacovigilance Services Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Pharmacovigilance Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pharmacovigilance Services Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pharmacovigilance Services Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Pharmacovigilance Services Sales Market Share by Country in 2024
Figure 53. Europe Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pharmacovigilance Services Market Size by Country in 2024
Figure 55. Germany Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pharmacovigilance Services Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Pharmacovigilance Services Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pharmacovigilance Services Market Size by Region in 2024
Figure 68. China Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pharmacovigilance Services Sales and Growth Rate (K Units)
Figure 79. South America Pharmacovigilance Services Sales Market Share by Country in 2024
Figure 80. South America Pharmacovigilance Services Market Size and Growth Rate (M USD)
Figure 81. South America Pharmacovigilance Services Market Size by Country in 2024
Figure 82. Brazil Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pharmacovigilance Services Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Pharmacovigilance Services Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pharmacovigilance Services Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pharmacovigilance Services Market Size by Region in 2024
Figure 92. Saudi Arabia Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pharmacovigilance Services Production Market Share by Region (2020-2025)
Figure 103. North America Pharmacovigilance Services Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Pharmacovigilance Services Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Pharmacovigilance Services Production (K Units) Growth Rate (2020-2025)
Figure 106. China Pharmacovigilance Services Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Pharmacovigilance Services Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Pharmacovigilance Services Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pharmacovigilance Services Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pharmacovigilance Services Market Share Forecast by Type (2026-2035)
Figure 111. Global Pharmacovigilance Services Sales Forecast by Application (2026-2035)
Figure 112. Global Pharmacovigilance Services Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Pharmacovigilance Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacovigilance Services Market Size (M USD), 2025-2035
Figure 5. Global Pharmacovigilance Services Market Size (M USD) (2020-2035)
Figure 6. Global Pharmacovigilance Services Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacovigilance Services Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pharmacovigilance Services Product Life Cycle
Figure 13. Pharmacovigilance Services Sales Share by Manufacturers in 2025
Figure 14. Global Pharmacovigilance Services Revenue Share by Manufacturers in 2025
Figure 15. Pharmacovigilance Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pharmacovigilance Services Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pharmacovigilance Services Revenue in 2025
Figure 18. Industry Chain Map of Pharmacovigilance Services
Figure 19. Global Pharmacovigilance Services Market PEST Analysis
Figure 20. Global Pharmacovigilance Services Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pharmacovigilance Services Market Share by Type
Figure 27. Sales Market Share of Pharmacovigilance Services by Type (2020-2025)
Figure 28. Sales Market Share of Pharmacovigilance Services by Type in 2025
Figure 29. Market Share of Pharmacovigilance Services by Type (2020-2025)
Figure 30. Market Share of Pharmacovigilance Services by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pharmacovigilance Services Market Share by Application
Figure 33. Global Pharmacovigilance Services Sales Market Share by Application (2020-2025)
Figure 34. Global Pharmacovigilance Services Sales Market Share by Application in 2025
Figure 35. Global Pharmacovigilance Services Market Share by Application (2020-2025)
Figure 36. Global Pharmacovigilance Services Market Share by Application in 2025
Figure 37. Global Pharmacovigilance Services Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pharmacovigilance Services Sales Market Share by Region (2020-2025)
Figure 39. Global Pharmacovigilance Services Market Size by Region (2020-2025)
Figure 40. North America Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Pharmacovigilance Services Sales Market Share by Country in 2024
Figure 43. North America Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pharmacovigilance Services Market Size by Country in 2024
Figure 45. U.S. Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pharmacovigilance Services Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Pharmacovigilance Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pharmacovigilance Services Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pharmacovigilance Services Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Pharmacovigilance Services Sales Market Share by Country in 2024
Figure 53. Europe Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pharmacovigilance Services Market Size by Country in 2024
Figure 55. Germany Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pharmacovigilance Services Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Pharmacovigilance Services Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pharmacovigilance Services Market Size by Region in 2024
Figure 68. China Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pharmacovigilance Services Sales and Growth Rate (K Units)
Figure 79. South America Pharmacovigilance Services Sales Market Share by Country in 2024
Figure 80. South America Pharmacovigilance Services Market Size and Growth Rate (M USD)
Figure 81. South America Pharmacovigilance Services Market Size by Country in 2024
Figure 82. Brazil Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pharmacovigilance Services Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Pharmacovigilance Services Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pharmacovigilance Services Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pharmacovigilance Services Market Size by Region in 2024
Figure 92. Saudi Arabia Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pharmacovigilance Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Pharmacovigilance Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pharmacovigilance Services Production Market Share by Region (2020-2025)
Figure 103. North America Pharmacovigilance Services Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Pharmacovigilance Services Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Pharmacovigilance Services Production (K Units) Growth Rate (2020-2025)
Figure 106. China Pharmacovigilance Services Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Pharmacovigilance Services Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Pharmacovigilance Services Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pharmacovigilance Services Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pharmacovigilance Services Market Share Forecast by Type (2026-2035)
Figure 111. Global Pharmacovigilance Services Sales Forecast by Application (2026-2035)
Figure 112. Global Pharmacovigilance Services Market Share Forecast by Application (2026-2035)
